We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. Read more about our Privacy Policy.

I got it!

Event
23 Jun 2020
Health

Fundamentals of RWE for Optimising Market Access

1-Day Training Course with Dr. Paul Craddy & Dr. Graham Foxon

Grasp the meaning, concepts, terminology, methodologies and research techniques of Real World Evidence (RWE) in the context of optimising Market Access - Know what each stakeholder type expects from RWE, which key data to use and how to develop a successful RWE study – Learn how to incorporate RWE into the product pre-launch process.

By attending this course you will learn;

  1. The fundamental concepts and principles for utilising Real World Evidence (RWE) towards optimising Market Access.
  2. The value RWE adds over RCTs over a product’s entire lifecycle.
  3. The terminology used within the world of RWE, such as the exact difference between Real World Evidence and Real World Data (RWD).
  4. Why RWE is important to regulators, payers, physicians and pharma and how to tailor the evidence to their specific needs.
  5. The common sources of data available for RWE and how to assess the robustness of the data.
  6. The critical success factors when developing a RWE study.
  7. How to effectively incorporate RWE into product launch decisions.

When

23 Jun 2020 @ 10:00 am

23 Jun 2020 @ 05:30 pm

Duration: 7 hours, 30 minutes


Where

Hilton Zurich Airport Hotel

Hohenbühlstrasse 10

Switzerland


Language

English en


Organised by

C.E.L.forpharma (deactivated)